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Many elements and compounds present in
the environment pose signiﬁcant health risks
to exposed individuals, and contribute to the
burden of disease for society. For any exposed
person the outcome may be affected by fac-
tors such as the degree of exposure, age, and
genetically determined differences in uptake,
elimination, or sensitivity to the toxic effects
of the substance. Investigation of such genetic
differences has been called toxicogenetics
(Orphanides and Kimber 2003), and
although most work has been done on toxic
reactions to therapeutic drugs, the approach
is equally applicable to the study of environ-
mental pollutants.
There has long been concern about
chronic toxic effects of the elements lead, cad-
mium, arsenic, and mercury, and an extensive
literature exists on their associations with a
range of conditions. For lead, the main com-
munity concerns are about impaired intellec-
tual development in infancy and childhood
(Canfield et al. 2003; Needleman 2004;
Pocock et al. 1994; Schwartz 1994). There is
also some evidence that higher lead values are
associated with increased adult mortality
(Lustberg and Silbergeld 2002, Schober et al.
2006), and cognitive decline in older people
(Weisskopf et al. 2004).
Environmental exposure is a precondition
for accumulation of these potentially toxic
elements, and major changes in exposure
(such as reduction in the lead content of
petrol) have produced changes in indices of
body burden (Luo et al. 2003; Pirkle et al.
1994; Schuhmacher et al. 1996; Wietlisbach
et al. 1995). However, within the general
population of a particular country or region
and at a particular time, variation in exposure
is probably only one of several factors influ-
encing accumulation and body burden. There
is evidence that blood lead concentrations are
quite stable within people who are exposed to
sources of lead only in the general environ-
ment, and that there are signiﬁcant between-
individual differences (Brody et al. 1994;
Delves et al. 1984). 
Individual differences in risk from lead
may be caused by differences in behavior (such
as the known effects of smoking and drinking)
or by genetic differences in metabolic or trans-
port processes. A number of attempts have
been made to test for effects of genetic poly-
morphisms on blood or bone lead values. To
date the results are mixed, with allelic associa-
tions both reported and denied for ALAD
(aminolevulinate, delta-, dehydratase; HGNC
ID 395) [all gene names, symbols, and
ID numbers are from the Human Gene
Nomenclature Committee (HGNC) available
at http://www.gene.ucl.ac.uk/nomenclature/
index.html and accessed 2 April 2007] and
VDR (vitamin D 1,25-dihydroxyvitamin D3)
receptor; HGNC ID 12679) (Kelada et al.
2001; Schwartz et al. 2000). Because of the
clinical association between iron deﬁciency and
lead toxicity, an association with iron status,
which may up- or down-regulate intestinal
divalent cation transporters, and specifically
with HFE (hemochromatosis; HGNC ID
4886) genotype has been proposed (Barton
et al. 1994; Wright et al. 2004). More gener-
ally, only a few studies have considered the
question of familial similarity of blood lead
and whether any such similarity is due to
shared genes or shared environment, and once
again the results are not deﬁnitive. A family-
based study (Hopper and Mathews 1983;
Hopper et al. 1982) showed evidence of shared
environmental effects in young siblings that
diminished with age, and no significant
spousal correlation, whereas a twin study
(Bjorkman et al. 2000) suggested additive
genetic effects in women and shared environ-
mental effects in men.
To clarify the degree of familial similarity
and to determine how far genetic and shared
and nonshared environmental factors contribute
to variation, we have measured lead concentra-
tions in blood samples from male and female
adult twins residing in Australia. The analysis
includes consideration of covariates such as sex,
age, smoking, alcohol intake, and place of resi-
dence; iron status; and HFE genotype. We have
also performed sib-pair linkage analysis using
data from dizygotic (DZ) twin pairs to identify
quantitative trait loci (QTLs) affecting blood
lead concentration.
Material and Methods
Subjects. The participants in this study were
twins enrolled in the Australian Twin
Registry, born between 1903 and 1964. They
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BACKGROUND: Lead is an environmental pollutant that causes acute and chronic toxicity. Surveys
have related mean blood lead concentrations to exogenous sources, including industrial activity, use
of lead-based paints, or trafﬁc density. However, there has been little investigation of individual dif-
ferences in lead absorption, distribution, or toxicity, or of genetic causes of such variation. 
OBJECTIVES: We assessed the genetic contribution to variation in blood lead concentration in adults
and conducted a preliminary search for genes producing such variation. 
METHODS: Erythrocyte lead concentration was measured by inductively coupled plasma mass spec-
trometry in venous blood samples from 2,926 Australian adult male and female twins. Mean lead
concentrations were compared by place of residence, social class and education, and by the subjects’
age, sex, alcohol intake, smoking habits, iron status, and HFE genotype.
RESULTS: After adjustment for these covariates, there was strong evidence of genetic effects but not
for shared environmental effects persisting into adult life. Linkage analysis showed suggestive evi-
dence (logarithm of odds = 2.63, genome-wide p = 0.170) for a quantitative trait locus affecting
blood lead values on chromosome 3 with the linkage peak close to SLC4A7, a gene whose product
affects lead transport. 
CONCLUSIONS: We conclude that genetic variation plays a significant role in determining lead
absorption, lead distribution within the body, or both.
KEY WORDS: blood lead, heritability, linkage, toxicogenetics, twin study. Environ Health Perspect
115:1224–1230 (2007). doi:10.1289/ehp.8847 available via http://dx.doi.org/ [Online 14 June 2007]completed a postal questionnaire in 1989, a
telephone interview in 1993–1994, and pro-
vided a blood sample in 1993–1996
(Whitfield et al. 1998). Although all were
twins, in some cases only one member of a
twin pair provided blood. We determined
zygosity from responses to questions about
physical similarity and the inability of others
to tell them apart, supplemented by blood
group information and, for those DZ pairs
participating in linkage projects (Beekman
et al. 2003), genome-wide microsatellite geno-
typing. Participants gave written informed
consent and the studies were approved by the
appropriate ethics committees.
Blood was collected from 1,134 men and
2,241 women. At the same visit, their height
and weight were measured and body mass
index (BMI) was calculated as weight
(kg)/[height (m)]2. Information on alcohol
intake (the number of drinks in the previous
week) was obtained by self-report question-
naires. Information on smoking was derived
from the 1989 questionnaire, and its use for
the 1993–1995 period has been validated in a
previous paper (Whitﬁeld et al. 2000b). Data
on the number of years of education (in seven
categories) and social class (in three categories)
were extracted from self-reports in the 1989
questionnaire (Miller et al. 2001). Participants’
addresses were categorized (using their post-
codes and a database on the geographic basis of
Australian postcodes) into urban, suburban, or
rural zones. This categorization was based on
distance from the central post office in the
closest major city (Whitfield et al. 2005).
Because the size and population density of the
cities vary, the distances used for classiﬁcation
also varied. For Sydney and Melbourne dis-
tances of 10 and 40 km were used to group
postcodes into urban, suburban and rural cate-
gories; for Adelaide, Brisbane, Hobart,
Newcastle, and Perth, 5 and 20 km; and for
Canberra and Darwin no urban category was
applied and a distance of 10 km divided sub-
urban from rural. 
Information on the subjects for whom
erythrocyte lead results are available is sum-
marized in Table 1. Most are of European
descent, with the majority having British or
Irish ancestry.
Laboratory procedures. Blood was col-
lected into EDTA, lithium heparin, and plain
tubes. Plasma, and then the buffy coat, were
removed from the anticoagulated tubes after
centrifugation and the remaining red cells
were stored at –20°C or below until analyzed.
Serum was obtained from the plain tubes and
stored at –70°C until analyzed. Erythrocytes
rather than whole blood were used for analy-
sis of lead because the original samples had
been separated to maximize the amounts of
plasma and buffy coat to be used for other
purposes. Essentially all the lead in blood is
bound to the erythrocytes, and plasma or
serum lead is < 1% of blood lead (Manton
et al. 2001; Schutz et al. 1996). In some cases
a portion of the erythrocytes had been diluted
with a sucrose solution to preserve them;
these were subsequently frozen under the
same conditions as the erythrocyte samples
and later used for lead measurement. Before
analysis, the erythrocytes were thawed at
room temperature and diluted 1:20 in ammo-
nia/EDTA solution containing rhodium as an
internal standard. Lead concentrations were
measured by inductively coupled plasma mass
spectrometry (ICP-MS) on a Perkin-Elmer
Elan 5000 (PerkinElmer Inc, Wellesley, MA,
USA) or Varian UltraMass (Varian Inc, Palo
Alto, CA, USA). Hemoglobin concentration
was then measured on the diluted samples
using the cyanmethemoglobin method. 
Analytical precision was calculated from
results on high and low quality control (QC)
materials that were analyzed with each batch
of samples. At a mean lead concentration of
0.14 µmol/L, the standard deviation was
0.018 µmol/L (coefﬁcient of variation 13.1%)
and at 1.81 µmol/L it was 0.169 µmol/L
(9.4%). 
Serum urate was measured by Boehringer
(Mannheim, Germany) reagents and method-
son a Hitachi 747 analyzer (Hatachi, Tokyo,
Japan); serum ferritin, transferrin, and iron
were measured using Roche Diagnostics (F.
Hoffmann-La Roche Ltd, Basel, Switzerland)
reagents and methods on a Hitachi 917 ana-
lyzer. HFE genotype was determined by poly-
merase chain reaction and allele-specific
oligonucleotide hybridization (Whitﬁeld et al.
2000a). 
Data analysis. A total of 2,926 individuals
had erythrocyte lead measured. In addition,
571 of the individuals had lead measurements
on two separate sample tubes, collected during
the same venipuncture but subsequently
processed and stored separately and analyzed
on different occasions. Assays were carried out
on 102 different days and the two QC sam-
ples were run at least once on each day. 
Tests for effects of covariates and estima-
tion of mean values by subgroups such as sex,
age, alcohol intake, or smoking were initially
performed using SPSS (SPSS Inc., Chicago,
IL, USA). Of the 2,926 people with erythro-
cyte lead data, information on age and sex
was available for all, but the numbers with
other covariate data varied, as shown in
Table 2.
Model ﬁtting to test for effects of genetic
and environmental sources of variation and
multivariate analysis of covariate effects were
performed using Mx (Neale 1999). Mx is a
matrix algebra interpreter and numerical opti-
mizer for statistical modeling, allowing simul-
taneous modeling of both ﬁxed effects on the
mean (e.g. from age, sex, and smoking status)
and random effects on variances and covari-
ances (e.g., additive genetic, shared, and non-
shared environmental sources of variance).
Use of Mx also overcomes potential statistical
problems that can arise with analysis of data
from related subjects, in this case twins. The
Mx data analysis was performed on results
from 2,832 people who had HFE genotypes
available; where necessary, missing covariate
data were replaced by the mean values. There
were 428 monozygotic (MZ) female, 165 MZ
male, 218 dizygotic (DZ) female, 90 DZ
male, and 222 DZ opposite-sex pairs, and
356 female and 230 male individuals whose
co-twin did not participate. 
Genetic variation in blood lead
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Table 1. Descriptive information for participants
with erythrocyte lead data.
Proportion of subjects
Grouping (%) or mean ± SD
Sex
Male 34
Female 66
Age (years) 46.0 ± 11.8
Drinks in previous week
None 34
1–7 39
8 –14 15
15–21 7
22–28 2.5
> 28 2.5
Smoking
Smokers 20
Nonsmokers 80
Residence
Urban 12 
Suburban 44 
Rural 44
Education
< 7 years 1
8–10 years 26
11–12 years 23
Apprenticeship, diploma 18 
Technical/teachers’ 14
college qualiﬁcation
University, ﬁrst degree 11
University, postgraduate training 7
Social class
Working 32
Middle 52 
Upper 15
BMI
< 25 54
25–30 34
> 30 12
Uric acid
Male (µmol/L) 0.386 ± 0.077
Female (µmol/L) 0.285 ± 0.073
Ferritin (log10 µg/L)
Male 2.253 ± 0.357
Female 1.812 ± 0.421
Transferrin saturation
Male 27.2 ± 9.2
Female 24.9 ± 10.8
HFE H63D
HH 74
HD 24
DD 2
HFE C282Y
CC 86
CY 13
YY 0.6Whitfield et al.
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To adjust for daily assay variation, a data
group was added to the Mx analysis estimat-
ing day effects from the results of the QC
samples. These were equated back to daily
deviations specified in the means model of
MZ and DZ twins. This allows the error vari-
ation inherent in measurement of lead in the
samples to be taken into account, with both
QC and twin samples contributing to the
maximum-likelihood estimation of and
adjustment for day effects. 
Effects of covariates. First, an analysis
including the data from duplicate measure-
ments was undertaken. Adjustments were made
for sample hemoglobin concentration, effects of
day-to-day analytical variation (incorporating
QC data and batch effects assessed from the
mean for all samples analysed within a batch),
sex, and age. At each step, the improvement in
goodness-of-ﬁt was assessed by the likelihood-
ratio chi-square test as each of the variables was
added. As anticipated, signiﬁcant effects were
found for day-to-day analytical variation, sam-
ple hemoglobin concentration, age, and sex (all
p < 10–6). The test–retest repeatability after
allowing for all these was r = 0.79, with 95%
conﬁdence interval (CI) 0.75–0.82.
Second, we tested for the effects of geo-
graphic, social, and metabolic characteristics
hypothesized to affect lead results. These were
sex, age, drinking habits, smoking status, resi-
dential location (categorized as urban, sub-
urban or rural, as deﬁned above), social class
(in three categories), educational level (seven
categories), BMI, serum uric acid, serum fer-
ritin and transferrin saturation, and HFE CY
and HD genotypes. To simplify the analysis,
the first or only lead value for each person
tested was used. Univariate analysis using
SPSS was supplemented with Mx analysis to
assess the independent effects of these covari-
ates. In this, the initial or baseline model con-
tained all the covariates; a series of submodels
were then ﬁtted in which one and only one of
the covariates was removed and the change in
goodness-of-ﬁt calculated to determine the sig-
niﬁcance of their independent contribution. 
Sources of variation. As the simultaneous
adjustment for all the covariate effects was com-
putationally intensive, we took advantage of a
new feature of Mx 1.57 (developed for this
application) and saved residuals from the model
containing all the covariates. These residuals
were used to ﬁt models of genetic and environ-
mental sources of variation to the within- and
between-pair covariances by zygosity group, as
previously described (Whitﬁeld et al. 2000a)
and also for the linkage analysis. Models were
initially tested with additive genetic (A), non-
shared environmental (E), and either dominant
genetic (D) or shared environmental (C)
sources of variation. The ACE or ADE models
were then compared with models containing
only A and E, only C and E, or E alone.
Linkage analysis. We performed a genome
scan of erythrocyte lead levels on 414 of the
Female Male
Grouping Mean SE n Mean SE n
All participants 0.358 0.005 1,925 0.445 0.006 1,001
p < 0.01
Age (years)
Up to 35 0.290 0.009 373 0.421 0.016 207
36–45 0.312 0.006 696 0.431 0.011 415
46–55 0.384 0.008 445 0.491 0.016 213
56–65 0.436 0.011 227 0.506 0.025 83
> 65 0.455 0.012 184 0.512 0.025 83
p < 0.001 p < 0.001
Drinks
None 0.341 0.006 761 0.426 0.015 219
1–7 0.340 0.006 805 0.424 0.012 339
Up to 14 0.392 0.011 235 0.471 0.016 201
15–21 0.382 0.020 75 0.492 0.020 132
22–28 0.540 0.032 29 0.519 0.034 44
> 28 0.539 0.058 9 0.545 0.029 63
p < 0.001 p < 0.001
Smoker
No 0.346 0.005 1,469 0.434 0.008 748
Yes 0.372 0.009 376 0.518 0.016 190
p < 0.05 p < 0.001
Residence
Urban 0.390 0.013 198 0.453 0.021 125
Suburban 0.347 0.006 772 0.449 0.011 441
Rural 0.344 0.006 821 0.468 0.012 374
p < 0.01 NS
Education
< 7 years 0.442 0.037 22 0.477 0.073 9
8–10 years 0.382 0.007 581 0.530 0.018 146
11–12 years 0.333 0.008 463 0.433 0.017 168
Apprenticeship, diploma 0.349 0.010 279 0.478 0.015 209
Technical/teachers’ 0.329 0.011 262 0.426 0.019 126
college qualiﬁcation
University ﬁrst degree 0.333 0.015 142 0.412 0.017 175
University postgraduate  0.321 0.018 96 0.402 0.021 106
training
p < 0.001 p < 0.001
Social class
Working 0.347 0.007 612 0.483 0.013 315
Middle 0.350 0.006 1,011 0.429 0.010 508
Upper 0.373 0.011 285 0.470 0.018 157
NS p < 0.01
Female Male
Grouping Mean SE n Mean SE n
BMI
< 25 0.348 0.005 1,124 0.442 0.011 434
25–30 0.366 0.008 523 0.465 0.011 452
> 30 0.345 0.011 253 0.459 0.023 101
NS NS
Urate
Q1 0.331 0.010 260 0.397 0.016 173
Q2 0.313 0.009 318 0.402 0.017 162
Q3 0.351 0.011 250 0.424 0.017 149
Q4 0.339 0.010 256 0.491 0.017 157
Q5 0.376 0.010 284 0.481 0.017 160
p < 0.001 p < 0.001
Ferritin
Q1 0.367 0.008 367 0.419 0.016 188
Q2 0.337 0.008 364 0.466 0.016 188
Q3 0.356 0.009 360 0.490 0.016 191
Q4 0.348 0.010 367 0.443 0.016 187
Q5 0.333 0.014 363 0.423 0.016 190
p < 0.05 p < 0.01
Tf sat
Q1 0.353 0.009 432 0.418 0.021 116
Q2 0.344 0.009 370 0.409 0.017 182
Q3 0.358 0.009 346 0.460 0.016 212
Q4 0.354 0.010 335 0.483 0.015 216
Q5 0.330 0.010 338 0.451 0.015 218
NS p < 0.05
HFE CY
CC 0.351 0.004 1,594 0.457 0.008 848
CY 0.379 0.011 259 0.462 0.021 116
YY 0.296 0.046 15 0.398 0.133 3
p < 0.05 NS
HFE HD
HH 0.354 0.005 1,402 0.463 0.009 684
HD 0.355 0.009 417 0.452 0.014 258
DD 0.335 0.028 42 0.343 0.051 21
NS NS
Table 2. Effects of sociodemographic, substance use and biological factors on erythrocyte lead (univariate analyses, adjusted for sample hemoglobin concentration).
NS, not signiﬁcant; Q, quintile; TF, transferrin saturation.DZ twin pairs. DNA was extracted from blood
or buccal swabs according to standard proce-
dures (Miller et al. 1988). Genotyping data
were collected from at least one of four genome
scans that had previously been performed for
other projects by the Mammalian Genotyping
Service (Marshfield, WI, USA; Leiden
University Medical Centre, the Netherlands)
(Beekman et al. 2003); Sequana Therapeutics
Inc. (La Jolla, CA, USA) and Gemini plc
(Cambridge, UK). Familial relationships were
veriﬁed using GRR (graphical representation of
relationship errors; Abecasis et al. 2001). After
errors were resolved, Mendelian segregation
inconsistencies were identified and removed
with SIB-PAIR computer software, version
0.99.9 (Duffy 2005a). Genotypes associated
with unlikely recombination events were subse-
quently ﬂagged and wiped with MERLIN ver-
sion 0.10.1 (Abecasis et al. 2002). The marker
genetic positions were interpolated via locally
weighted linear regression from the National
Center for Biotechnology Information Build
34.3 physical map positions (National Center
for Biotechnology Information 2007) and the
published “Rutger’s” (Kong et al. 2004)
genetic map (Duffy 2005b). Genetic positions
are expressed in Kosambi centiMorgans (cM).
Of the 414 available sib-pairs, 388 (94%) were
genotyped at 300–1,544 markers (mean 730)
and 28 (6%) at less than 300 markers. Linkage
analyses with or without this latter group of
sib-pairs provided similar results, so we present
only the analysis including all families. The
mean intermarker distance for sib-pairs with
300 or more markers in common, estimated
for each sib-pair and then averaged across the
388 pairs, was 5.7 cM (SD = 2.9; range,
1.8–49.4). The average multipoint entropy
information content (Kruglyak et al. 1996) was
0.54, computed with MERLIN at the marker
closest to the middle of the chromosome and
averaged over the 22 autosomes. The average
heterozygosity for the autosomal markers was
75%. Finally, sibling IBD (identity by descent)
sharing was estimated via multipoint methods
on a 5-cM grid and maximum likelihood uni-
variate variance components linkage analysis
performed as implemented in MERLIN, after
adjustment for all the tested covariates. At
every 5 cM, a 1-degree-of-freedom (df) loga-
rithm of odds (LOD) score was computed,
which is distributed as a 50:50 mixture of a
point probability mass at 0 and a χ1
2, being
equivalent to the original parametric LOD
score proposed by Morton (1955).
Empirical genome-wide thresholds. Trait-
speciﬁc empirical genome-wide suggestive and
significant thresholds were calculated using
1,000 gene-dropping simulations as described
by Abecasis et al. (2004). For each simulation,
we used MERLIN to generate a new data set
with the original phenotypes but with new
genotypes simulated under the null hypothesis
of no linkage for all autosomal markers, retain-
ing the same allele frequencies, marker spacing,
and missing data pattern. Multipoint IBDs for
each simulation replicate were then computed
and linkage analysis performed as described
above. We recorded the highest peak observed
for each chromosome and counted the number
of chromosomes exhibiting an LOD score
equal to or greater than a given threshold p.
The empirical genome-wide thresholds for sug-
gestive or significant linkage (Lander and
Kruglyak 1995) were deﬁned as the thresholds
p for which we observed on average 1 or 0.05
peaks per simulation with a LOD score ≥ p,
respectively.
Results
Effects of covariates. The mean value for lead
concentration in all the samples before adjust-
ment for covariates was 0.388 µmol/L, and the
mean hemoglobin concentration was 235 g/L.
The erythrocyte lead concentrations, extrapo-
lated to whole blood with an average hemoglo-
bin concentration of 140 g/L, imply mean lead
concentrations in whole blood of 0.265 µmol/L
(SD 0.165) for men, and 0.213 µmol/L (SD
0.125) for women. The results of the signiﬁ-
cance tests for the demographic and metabolic
factors tested for their associations with the
erythrocyte lead values are summarized in
Table 2. Of the variables hypothesized to affect
or co-vary with lead concentrations, the
strongest univariate associations were for age,
alcohol intake, sex, serum uric acid concentra-
tion, and smoking status. The geographic and
social indicators, place of residence, and social
class, had variable or nonsigniﬁcant effects, but
educational level had signiﬁcant and consistent
effects in both men and women. 
Multivariate analysis (Table 3) showed that
sex, age, drinking, and smoking all had inde-
pendent effects. Educational level showed only
marginally significant effects in multivariate
analysis, and both residential location and
social class were nonsignificant. BMI and
serum ferritin had signiﬁcant but small effects.
Other factors associated with iron status, the
serum transferrin saturation and HFE geno-
types, had no independent effect. A highly sig-
niﬁcant and independent association between
erythrocyte lead and plasma uric acid was con-
ﬁrmed. Among the results that were found to
be statistically signiﬁcant, men had higher ery-
throcyte lead values than women. Mean lead
values rose with age, with smoking, and with
increasing alcohol intake. Both ferritin and
urate values were positively correlated with
erythrocyte lead concentration. 
Sources of variation. After adjustment for
all the covariate effects, the correlations
between residuals for members of twin pairs,
by zygosity were rMZF 0.43, rMZM 0.46, rDZF
0.24 rDZM 0.21, and rDZFM 0.18. There was
no evidence of differences in correlation
between men and women, and pooled zygos-
ity correlations were rMZ 0.43 (95% CI,
0.37–0.50), rDZ 0.22 (95% CI, 0.14–0.30).
These correlations were affected very little by
dropping covariates from the model (Table 3)
except in the case of age. Because members of
a twin pair are of the same age regardless of
zygosity, and age had a substantial effect on
lead values, dropping the age effect produced
an increase in within-pair correlations in both
MZ and DZ pairs.
Tests of the sources of residual variation in
erythrocyte lead are shown in Table 4. First,
there was clear evidence of familial similarity
because the model containing only nonshared
environmental effects (E) was very strongly
rejected when compared with any of the others.
Second, the source of this family resemblance
was genetic rather than due to long-term effects
of the shared family environment. The AE
Genetic variation in blood lead
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Table 3. Effects of sociodemographic, substance use, and biological factors on erythrocyte lead (multivari-
ate analysis).
Percent of
Models –2LL df Δχ2 Δdf p-Value variance rMZ rDZ
Baseline –4007.86 3,138 — — — — 0.425 0.213
Sex –3956.39 3,139 51.46 1 < 0.0001 3.2 0.430 0.199
Age and age2 –3772.10 3,140 235.76 2 < 0.0001 18.7 0.476 0.275
Drinking –3929.50 3,139 78.36 1 < 0.0001 5.7 0.428 0.221
Smoking –3971.73 3,139 36.12 1 < 0.0001 2.6 0.425 0.214
Residence –4005.63 3,139 2.23 1 0.136 < 1 0.426 0.213
Education –4002.30 3,139 5.56 1 0.018 < 1 0.427 0.211
Social class –4007.84 3,139 0.02 1 0.888 < 1 0.425 0.213
BMI –3998.34 3,139 9.52 1 0.002 < 1 0.421 0.212
Uric acid –3961.75 3,139 46.10 1 < 0.0001 3.2 0.434 0.204
Ferritin –3998.35 3,139 9.50 1 0.002 < 1 0.427 0.207
Saturation –4005.52 3,139 2.34 1 0.126 < 1 0.424 0.215
HFE H63D –4006.70 3,139 1.16 1 0.282 < 1 0.426 0.215
HFE C282Y –4007.05 3,139 0.80 1 0.371 < 1 0.426 0.214
–2LL, –2 times the log likelihood. The baseline model includes adjustment for effects of all covariates listed, plus sample
haemoglobin concentration and day effects. Note that the number of degrees of freedom in the second column reﬂects
both the number of subjects tested and the number of quality control sample results in the QC data group. Each of the listed
covariates in turn was dropped from the full model and then replaced, and the change in goodness of ﬁt (Δχ2), and the
change in total variance were estimated. MZ and DZ pair correlations are shown for the baseline model including all
covariates, and after dropping each.model, containing additive genetic and non-
shared environmental sources of variation, gave
a much better ﬁt to the data than the CE model
containing shared and nonshared environmen-
tal sources of variation (p = 0.00003). When
the AE model was expanded to contain either
C (shared environment) or D (dominant
genetic effects) both the C and D effects were
estimated at zero. However, the upper 95% CI
for the estimate of C in the ACE model is 16%,
so we cannot exclude some persisting effects of
the shared environment.
Linkage analysis. In the linkage analysis, the
highest LOD score was found on chromo-
some 3 (2.63 at D3S1619, or 2.59 at 57.2 cM
on the 5 cM grid). The empirical signiﬁcance
threshold was estimated by simulation, and it
was found that a value ≥ 2.63 was observed in
only 170 of 1,000 simulations (i.e., genome-
wide p = 0.17). Three other regions showed
peak LOD scores > 1.0. These were on chro-
mosomes 13 (1.17 at D13S787), 17 (1.27 at
ATA78D02), and 20 (1.42 at D20S107). The
empirical genome-wide threshold for suggestive
linkage was 1.59 and for significant linkage
3.00. Thus only the chromosome 3 peak
exceeds the suggested threshold. The overall
linkage results, and an enlarged plot for chro-
mosome 3, are shown in Figures 1 and 2.
Discussion
Sources of variation in blood lead. We set out
to investigate the causes of variation in blood
lead concentrations in the general population
of Australia, using samples that we had col-
lected from a large series of adult twins living
throughout the country in the early 1990s.
One expectation was that geographic differ-
ences, particularly those between inner-city
and rural environments, would be a signifi-
cant source of variation. Other influences
shared within families, such as social class or
perhaps educational levels, might also be
signiﬁcant. There was indeed a strong familial
component to lead variation, but this proved
to be genetic in origin. This leads to a differ-
ent perspective on the true sources of varia-
tion within this population.
One major ﬁnding is the signiﬁcant heri-
tability of blood lead concentrations. The data
clearly indicate the existence of genetic contri-
butions to variation in blood lead, with MZ
pair correlations twice DZ pair correlations and
no evidence of differences in correlation
between male and female pairs or between
same-sex and opposite-sex DZ pairs. These cor-
relations were little changed when covariate
effects were dropped from the model, remain-
ing twice as great in MZ as in DZ pairs, as
shown in Table 3. Estimated heritability was
just over 40% (Table 4). There is little prior
information on variation in blood lead within a
twin- or family-study design. The conclusions
of two previous studies differ from each other
and also from our results. A comparison of
blood lead levels within families (Hopper and
Mathews 1983) led to the conclusion that the
shared environment was important in children
because high correlations were observed for
young siblings living together, but these correla-
tions diminished with age. The only previous
twin study (Bjorkman et al. 2000) found evi-
dence for genetic effects on blood lead in
women but not in men; in the men the high
within-DZ-pair correlation suggested persisting
Whitfield et al.
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Table 4. Tests of alternative models of sources of variation in erythrocyte lead after adjustment for covariates. 
Compared Proportions of variance
Model –2LL df against Δχ2 Δdf p-Value A% (95% CI) C% (95% CI) D% (95% CI) E% (95% CI)
ACE –2,019.93 2,828 42.5 (23–48) 0.0 (0–16) — 57.5 (52–64)
ADE –2,019.93 2,828 42.5 (10–48) — 0.0 (0 to 34) 57.5 (51–64)
AE –2,019.93 2,829 ACE 0 1 1.00 42.5 (36–48) — — 57.5 (52–64)
CE –2,002.31 2,829 ACE 17.62 1 0.00003 — 32.0 (27–37) — 68.0 (63–73)
E –1,880.84 2,830 AE 139.09 1 < 10–6 — — — 100.0
Abbreviations: LL, log likelihood; df, degrees of freedom. Comparison between models was based on the change in goodness-of-ﬁt between the model and the data (Δχ2) as potential
sources of variation were removed. Sources of variation: A, effects due to additive actions of genes; D, effects due to actions of dominant genes; C, effects due to common environment
shared by members of a twin pair; and E, effects due to unique environment not shared by members of a twin pair.
Figure 1. Results of linkage analysis for erythrocyte lead (residuals after adjusting for covariates). Each panel represents one chromosome; the x-axis shows
genetic distance from the p-terminal end, and centromeres are indicated by ﬁlled triangles below this axis. The y-axis shows LOD scores, and the lines at 3.0 and
1.6 on the y-axis represent the empirical “signiﬁcant” and “suggestive” values for genome-wide signiﬁcance as determined by simulation. 
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0effects of shared environment, even though the
subjects were 49–86 years of age and had pre-
sumably lived apart for 30–70 years. 
Although some shared environmental
effects could not be excluded in our data (up
to 16% of variance; Table 4), the maximum-
likelihood estimate was zero. This is contrary
to the earlier Australian ﬁnding of the impor-
tance of familial environment (Hopper et al.
1982). However these results may be recon-
ciled if the relative importance of genetic and
environmental variation has changed over
time, particularly as the amount of lead enter-
ing the environment from petrol has decreased
and environmental differences have been
reduced. In Switzerland at least, there was a
convergence of city and country blood lead
values as unleaded petrol came into use
(Wietlisbach et al. 1995).
QTLs for blood lead. The second major
ﬁnding arises from the linkage results. Despite
the limited power of linkage analysis to detect
QTLs with only 416 DZ twin pairs, we found
a region of suggestive linkage on chromosome 3
with an LOD score of 2.65 at D3S2396
(Figure 2). This marker is located 54.06 cM or
29.76 Mb from the p-terminal end of the chro-
mosome. Examination of a list of genes within
the 1-LOD confidence interval of this peak,
from 24 to 39 Mb, shows 62 genes or putative
genes. Many are unidentiﬁed and nearly all lack
obvious relevance for blood lead. However one,
SLC4A7 (solute carrier family 4, sodium bicar-
bonate cotransporter, member 7; HGNC ID
11033), codes for a bicarbonate transporter
(Pushkin et al. 1999). Movement of lead into
erythrocytes (and possibly other tissues) has
been shown to depend on bicarbonate trans-
port, being blocked by inhibitors of anion
transport (Bannon et al. 2000; Simons 1986).
This leads to the hypothesis that polymorphic
variation in SLC4A7, in coding or regulatory
sequences, produces the genetic variation in
erythrocyte lead concentration that we
observed. Although we recognize that other
genes may be the source of the chromosome 3
linkage peak through mechanisms that are not
immediately apparent, SLC4A7 is a good can-
didate and demands further investigation.
Another region of interest is on chromo-
some 20. The peak LOD score of 1.42 does
not exceed the suggestive threshold but coin-
cides with the location of another gene, which
may affect anion transport and therefore the
accumulation of lead within cells. This gene,
EPB41L1 (erythrocyte membrane protein
band 4.1-like-1, HGNC ID 3378), codes for a
member of the protein 4.1 family. These
proteins bind to ion transport proteins and
provide a physical connection between the
cytoskeleton and the cell membrane. It is
believed that such binding plays a role in regu-
lating the activity of ion transport proteins
(Denker and Barber 2002). Although the chro-
mosome 20 linkage peak is not strong, this
possible physiologic connection with the more
substantial chromosome 3 peak is of interest.
Conversely, we can compare our linkage
results to the locations of candidate genes. These
include ALAD (chromosome 9, 111.5 Mb),
VDR (chromosome 12, 46.5 Mb), HFE (chro-
mosome 6, 26.2 Mb), metallothioneins (MT1B
metallothionein 1B, HGNC ID 7394; MT1E
metallothionein 1E, HGNC ID 7397; MT1G
metallothionein 1G, HGNC ID 7399; MT1M
metallothionein 1M, HGNC ID 14276;
MT2A metallothionein 2A, HGNC ID 7406;
MT3 metallothionein 3, HGNC ID 7408;
MT4 metallothionein 4, HGNC ID 18705; all
chromosomes 16, 56.4 Mb), divalent metal
transporter (SLC11A2; solute carrier family 11
(proton-coupled divalent metal ion trans-
porters), member 2 , HGNC ID 10908; chro-
mosome 12, 49.7 Mb), hepcidin (HAMP;
hepcidin antimicrobial peptide, HGNC ID
15598; chromosome 19, 40.5 Mb), and iron
regulatory proteins (ACO1; aconitase 1, solu-
ble, HGNC ID 117; chromosome 9, 32.4 Mb
and IREB2, iron-responsive element binding
protein 2, HGNC ID 6115; chromosome 15,
76.4 Mb). Although HFE is close to a minor
peak (LOD score 0.89 at D6S2439, at
24.4 Mb, less than 2 Mb from HFE), none of
the candidate genes are situated in genomic
regions with LOD scores above 1.0 in our
linkage analysis. This does not rule out their
involvement at levels below our threshold for
detection by linkage, which has less power than
allelic association to detect small effects. It is
also possible that some effects are conﬁned to a
comparatively rare genotype, such as the YY
genotype for HFE, and the number of DZ
pairs with such genotypes is insufficient to
detect linkage.
Effects of measured covariates. Third, we
have tested for effects of a number of covariates
that have been reported to affect blood lead
levels in other population-based studies. The
significant effects of age, sex, smoking, and
alcohol use are similar to those previously
reported (Brody et al. 1994; Shaper et al. 1982;
Weyermann and Brenner 1997). Mean values
are consistent with those reported elsewhere;
our mean value for men is similar to that
reported for non-Hispanic white men in the
United States in 1988–1991 (0.18–0.23
µmol/L, depending on age group), but our
mean for women is higher than for U.S. non-
Hispanic white women (0.08–0.17 µmol/L)
(Brody et al. 1994). Comparable adult
Australian data are not available, but a survey
of children in Australia in 1995 found a mean
value of 0.28 µmol/L (Donovan 1996). It is
not clear why the difference between adult
male and female lead concentrations should be
less in Australia than in the United States.
Education showed a trend for decreasing
lead values with increasing years of education.
This association has been described in other
studies. In the NHANES III study (Brody et al.
1994) a difference was found between high
school graduates and others, and our data
(Table 2) suggest the type of post-school train-
ing or education undertaken makes little
further difference. Negative results in the multi-
variate analysis may be because of the nonlinear
relationship between the educational grouping
and lead levels or association between education
and other predictor variables in the analysis.
Other measures of environmental exposure
(residential location) and socioeconomic status
(self-reported social class) did not show inde-
pendent effects on lead concentration, although
minor effects of residential location were seen
for women in the univariate analysis. U.S. data
(Brody et al. 1994) do suggest that place of resi-
dence affects blood lead, but the contrasted
areas (central city with population > 1 million,
< 1 million, or other locations) are not easily
comparable with our classifications and the
nature of the central-city environment differs in
Australia. To some extent, education, residence,
and social class will be similar within twin pairs;
shared environmental effects on residential loca-
tion persist into adult life and genetic effects
displace them in the older participants in this
study (Whitﬁeld et al. 2005). However, because
the measures of environmental exposure did
not show signiﬁcant effects on lead levels, they
are unlikely to have affected the comparison of
MZ and DZ pair similarities.
The association with ferritin in the multi-
variate analysis was in a positive direction;
higher lead values were found in those with
higher ferritin. However, the univariate analy-
sis failed to show a clear trend across the fer-
ritin categories, in either men or women. We
found no signiﬁcant associations between lead
and transferrin saturation. For HFE genotype,
results were nonsignificant, but it may be
noted that in both men and women the
minor allele homozygotes (YY or DD) had
the lowest mean lead levels. Lower bone lead
values in carriers of variant HFE alleles have
been reported by others (Wright et al. 2004).
Genetic variation in blood lead
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Figure 2. Linkage results for chromosome 3. The
x-axis shows genetic distance from the p-terminal
end and the y-axis shows LOD scores, and the
lines at 3.0 and 1.6 on the y-axis represent the
empirical “signiﬁcant” and “suggestive” values for
genome-wide signiﬁcance as determined by simu-
lation. Arrow indicates the position of SLC4A7.
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The magnitude of the positive association
between uric acid and lead was unexpected,
although some previous reports have shown
associations in the general population (Lin
et al. 2002; Shadick et al. 2000). It appears
that lead exposure reduces the renal excretion
of urate because chelation therapy increases
urate clearance (Lin et al. 2002). 
Limitations and Conclusions 
The conclusions of this study, although clear,
are subject to a number of limitations. First,
the samples were collected about 10 years ago,
and environmental lead has decreased further
since that time. This environmental change
will have reduced the mean values for blood
(or erythrocyte) lead in the population and
may have reduced variability. Second, our
study was on adults from the general popula-
tion and cannot directly illuminate causes of
variation in vulnerable groups such as young
children or more highly exposed groups such
as lead workers. Because much of the lead
exposure of infants is from ingestion of lead
paint residues in soil surrounding older houses,
the balance between environmental and
genetic causes of variation may be different in
children than in adults. Third, we only mea-
sured lead in blood, so the factors described
may affect lead absorption and body burden,
or only its distribution within the body. In the
latter case some people could have high blood
lead levels but an acceptable total body content
or vice versa. Distinguishing between these
possibilities would require measurement of
lead in bones or perhaps in deciduous teeth.
Finally, it is sometimes claimed that MZ twin
pairs are more similar in their environments
than DZ pairs. In studies of biochemical char-
acteristics in adult twins, this is unlikely to be
important; even if MZ pairs did share more of
their environmental exposure to lead up to 16
or 18 years of age, it would be remarkable if
this produced a greater similarity in blood
concentrations some 30 years later.
Overall, our results emphasize the signiﬁ-
cance of genetic factors in determining individ-
ual differences in blood lead concentration, at
least in adults. They also suggest a role for an
ion transporter gene whose product mediates
lead transport into cells. However, we should
not infer from this that environmental expo-
sure is unimportant or that efforts to reduce
exposure to lead have low priority or lack efﬁ-
cacy. To modify a well-known metaphor, a
falling tide will lower all boats. 
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